enVVeno Medical Corporation NVNO
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.72M | 1.95M | 2.40M | 2.59M | 3.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.80M | 4.06M | 4.35M | 5.17M | 6.12M |
| Operating Income | -3.80M | -4.06M | -4.35M | -5.17M | -6.12M |
| Income Before Tax | -3.60M | -3.85M | -3.74M | -4.54M | -6.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.60M | -3.85M | -3.74M | -4.54M | -6.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.60M | -3.85M | -3.74M | -4.54M | -6.69M |
| EBIT | -3.80M | -4.06M | -4.35M | -5.17M | -6.12M |
| EBITDA | -3.77M | -4.03M | -4.32M | -5.14M | -6.09M |
| EPS Basic | -5.37 | -5.89 | -6.05 | -7.88 | -11.52 |
| Normalized Basic EPS | -3.53 | -3.86 | -4.30 | -5.43 | -6.38 |
| EPS Diluted | -5.37 | -5.89 | -6.05 | -7.88 | -11.52 |
| Normalized Diluted EPS | -3.53 | -3.86 | -4.30 | -5.43 | -6.38 |
| Average Basic Shares Outstanding | 671.00K | 654.00K | 617.20K | 575.90K | 581.00K |
| Average Diluted Shares Outstanding | 671.00K | 654.00K | 617.20K | 575.90K | 581.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |